[New type pump for continuous arterial infusion].

T Mori; T Takahashi

Home/Archive/PubMed

PubMed · 3415252

[New type pump for continuous arterial infusion].

T Mori·T Takahashi

View original source ↗Export metadata ↓

Abstract

We have been attempting to improve the arterial infusion pump, and two new type instruments have been completed. One is the normopressure type and another is the high pressure type. The normopressure type pump is similar to the usual infusion pump but it is much more compact and light. The size is 12.5 x 12.5 x 5 cm, and the weight is 250 grams when the bag is full of drug. Therefore, it is more comfortable and enables patients to continue the infusion longer than usual. An alarm mechanism to indicate a low power of battery and a changeable function for infusing speed (2.5-20 ml/day) are equipped. The energy source is obtained from an alkaline battery (6-P type) which is easily bought on the market. The maximum volume of the bag for drug is 50 ml. The purpose of the high-pressure pump is the infusion of fluids of higher viscosity (e.g., adriamycin) or a drug requiring a large volume over a short time. The maximum pressure at the tip of the catheter is 4 kg/cm2. If the pressure is beyond this level, the pump stops and the alarm sounds. The size is 30 x 5 x 5 cm and weight is 650 grams. The patient can easily move during infusion with the pump. These two new pumps for arterial infusion promise a greater choice of drugs and free combination of therapy in the future.

Explore related subjects

Humans Infusion Pumps Infusions, Intra-Arterial Pressure English Abstract Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

T Mori, T Takahashi. 1988. [New type pump for continuous arterial infusion].. https://pubmed.ncbi.nlm.nih.gov/3415252/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2027

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗

PubMed2027

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗

PubMed2027

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗